UnitedHealth Group (UNH) Now Covered by Goldman Sachs Group

Stock analysts at Goldman Sachs Group began coverage on shares of UnitedHealth Group (NYSE:UNH) in a research note issued to investors on Wednesday, The Fly reports. The firm set a “buy” rating on the healthcare conglomerate’s stock.

A number of other analysts have also recently weighed in on the stock. Credit Suisse Group reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday, December 27th. Cantor Fitzgerald reiterated a “buy” rating and set a $235.00 price target on shares of UnitedHealth Group in a research note on Monday, December 25th. ValuEngine cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, December 7th. Raymond James Financial reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday, December 6th. Finally, Sanford C. Bernstein increased their price target on shares of UnitedHealth Group from $219.00 to $246.00 and gave the stock an “outperform” rating in a research note on Friday, December 1st. Three analysts have rated the stock with a hold rating and twenty-five have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $224.98.

UnitedHealth Group (NYSE:UNH) opened at $221.16 on Wednesday. UnitedHealth Group has a twelve month low of $156.09 and a twelve month high of $231.77. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. The stock has a market cap of $213,640.63, a price-to-earnings ratio of 24.52, a PEG ratio of 1.51 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The business had revenue of $50.32 billion during the quarter, compared to analysts’ expectations of $50.38 billion. During the same quarter in the prior year, the business posted $2.17 EPS. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. sell-side analysts expect that UnitedHealth Group will post 9.99 earnings per share for the current year.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the completion of the transaction, the director now owns 61,137 shares in the company, valued at approximately $13,652,503.47. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Larry C. Renfro sold 22,598 shares of the company’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the transaction, the chief executive officer now owns 195,314 shares of the company’s stock, valued at approximately $43,310,879.50. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 34,630 shares of company stock valued at $7,669,416. 0.89% of the stock is owned by insiders.

Institutional investors have recently made changes to their positions in the business. Beacon Capital Management purchased a new position in UnitedHealth Group during the 4th quarter valued at about $0. Proficio Capital Partners purchased a new position in UnitedHealth Group during the 4th quarter valued at about $29,000. Coconut Grove Bank increased its holdings in UnitedHealth Group by 19.5% during the 3rd quarter. Coconut Grove Bank now owns 736 shares of the healthcare conglomerate’s stock valued at $103,000 after acquiring an additional 120 shares in the last quarter. First Personal Financial Services increased its holdings in UnitedHealth Group by 36.9% during the 3rd quarter. First Personal Financial Services now owns 742 shares of the healthcare conglomerate’s stock valued at $104,000 after acquiring an additional 200 shares in the last quarter. Finally, Patriot Financial Group Insurance Agency LLC increased its holdings in UnitedHealth Group by 1,722.9% during the 1st quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after acquiring an additional 603 shares in the last quarter. Institutional investors own 86.01% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was reported by American Banking and Market News and is the property of of American Banking and Market News. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be viewed at https://www.americanbankingnews.com/2018/01/03/unitedhealth-group-unh-now-covered-by-goldman-sachs-group.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.